Regulatory & Legal

Black Stone Minerals maintains its $0.30 quarterly distribution, offering stability to investors as all eyes turn to its upcoming Q1 earnings report.

From AI's energy crisis to electric skies, a new report spotlights the companies tackling sustainability's biggest challenges. Here's who is leading the charge.

A new financial deal shines a light on Modeyso, a breakthrough therapy for a rare pediatric brain cancer, linking Wall Street to life-saving innovation.

Two Winston-Salem credit unions will combine, creating a regional giant and reshaping North Carolina's competitive financial landscape. What does it mean?

As its leaders vie for a top entrepreneurial award, a look at how GenScript quietly became an indispensable engine for global scientific breakthroughs.

Celebrating two decades, a massive SoCal development proves large-scale conservation and community building can coexist. But what is the model's true cost?

From an AI-powered undersea lab to shaping global shark laws, discover how one university is leading a multi-front battle to save our oceans.

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

As cyberattacks and IT failures plague hospitals, a new BICSI standard offers a blueprint for building resilient ICT infrastructure to protect patient safety.

New TempLock™ tech in the SherpaPak® system aims to keep donor hearts stable longer, potentially expanding the reach of life-saving transplants.

A novel, minimally invasive nerve ablation technology shows long-term promise for relieving severe pancreatic cancer pain, a major unmet medical need.

A multi-billion dollar fund for California's disabled workers faces a crisis, sparking a fight over fast-tracked reforms and legislative transparency.

Cass Information Systems appoints Energizer's John Drabik to its board as three veterans retire, a move signaling a sharp focus on financial strategy.

Amid a tough DOE review culling many grants, one firm saw all its clients advance, unblocking $606M and revealing a new model for federal funding success.

As its foundation marks 3 years of social good, the energy giant faces tough questions over the environmental cost of its floating power plants.

As companies struggle with fragmented and insecure AI, OakTruss Group's new AI Cube™ offers a structured framework for secure and strategic investment.

A California health plan is investing millions to build homes, not hospitals, betting that stable housing is the key to solving LA's health and homeless crises.

A novel drug derived from ibogaine, DMX-1001 aims to repair brain circuits damaged by alcohol. The FDA has now cleared it for Phase 2 human trials.

As Varex prepares its Q2 report, investors watch to see if booming industrial sales and medical innovations can sustain its impressive market momentum.

Foxit's new app for ChatGPT enables full document workflows inside the chat, tackling AI's 'verification burden' and challenging rivals in the new AI workspace.